realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL
Completed
Conditions studied: Diffuse Large B-cell Lymphoma
In brief
The realMIND study is a multicenter, observational study intended to further characterize the safety and effectiveness data of US patients (with a focus on racial and ethnic minority patients) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), treated with tafasitamab in combination with lenalidomide.
Key facts
- Study ID
- NCT04981795
- Run by
- Incyte Corporation
- People needed
- 102
- Starts
- 2021-09-20
- Expected to finish
- 2026-01-23
- Last updated by the study team
- 2026-04-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Initiated or initiating tafasitamab treatment in the context of an interventional study.
Where it is running
- Alabama Oncology — Birmingham, Alabama, United States
- Clearview Cancer Institute — Huntsville, Alabama, United States
- University of California, Irvine Medical Center — Orange, California, United States
- McFarland Clinic P.C. — Ames, Iowa, United States
- Mission Cancer and Blood — Des Moines, Iowa, United States
- Tulane Cancer Center — New Orleans, Louisiana, United States
- American Oncology Partners of Maryland PA — Bethesda, Maryland, United States
- University of Michigan Comprehensive Cancer Center Michigan Medicine — Ann Arbor, Michigan, United States
- Henry Ford Health System — Detroit, Michigan, United States
- Morristown Medical Center — Morristown, New Jersey, United States
- Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States
- Westchester Medical Center — Hawthorne, New York, United States
- Levine Cancer Institute — Charlotte, North Carolina, United States
- Duke University — Durham, North Carolina, United States
- VA Medical Center - Durham — Durham, North Carolina, United States
- Leo Jenkins Cancer Center/ECU School of Medicine — Greenville, North Carolina, United States
- Mercy Medical Center — Canton, Ohio, United States
- Ohio Health Marion Area Physicians — Marion, Ohio, United States
- Tri County Hematology & Oncology Associates, Inc — Massillon, Ohio, United States
- Integris Cancer Institute of Oklahoma — Oklahoma City, Oklahoma, United States
- Thomas Jefferson University — Philadelphia, Pennsylvania, United States
- Lankenau Medical Center — Wynnewood, Pennsylvania, United States
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States
- UW Medicine — Seattle, Washington, United States
- Yakima Valley Memorial Hospital/North Star Lodge — Yakima, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.